Taken together with sc-RNA seq studies identifying downregulation Cx3cr1 in plaque associated microglia as a molecular event that shapes microglial activation in AD [20–22], CX3CR1-signaling has emerged as a critical determinant of long-term pathological outcomes in AD. This evidence concerns the gene CX3CR1 and Alzheimer disease.